AgeX Therapeutics, Inc. (NYSE American:AGE)
About the company
AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
Stock price
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
Revenues - Income - Cash Flows (in USD Million)
Margins (in %)
Return on capital (in %)
Ratios (in %)
Industry margins
Industry workforces
Industry revenues and market cap
Industry ratios
90-days Stock Price Forecast (in %)
Industry peers
| Name | Ticker | Market capitalization (in USD Million) | Revenues (in USD Million) | Price/Book | Price/Earning | Net margin (in %) |
|---|---|---|---|---|---|---|
| Johnson & Johnson | JNJ | 391056.16 | 82729.00 | 6.28 | 22.79 | 20.75 |
| Pfizer Inc. | PFE | 198619.60 | 50660.00 | 3.01 | 12.57 | 31.17 |
| Merck & Co., Inc. | MRK | 196889.19 | 48081.00 | 7.39 | 19.43 | 21.10 |
| Eli Lilly & Co. | LLY | 148789.44 | 23087.00 | 50.49 | 26.23 | 23.97 |
| AbbVie, Inc. | ABBV | 145224.24 | 34057.00 | -23.24 | 17.32 | 24.65 |
| Bristol Myers Squibb Co. | BMY | 107221.81 | 31006.00 | 2.60 | 91.16 | 3.08 |
| Repligen Corp. | RGEN | 6248.01 | 286.00 | 5.99 | 272.24 | 8.11 |
| Reata Pharmaceuticals, Inc. | RETA | 4786.40 | 20.00 | 22.67 | -15.39 | -150.30 |
| Nektar Therapeutics | NKTR | 4111.36 | 137.00 | 3.21 | -8.95 | -335.62 |
| Biohaven Pharmaceutical Holding Co. Ltd. | BHVN | 3862.82 | 1.00 | 35.71 | -5.91 | None |
| Allakos, Inc. | ALLK | 3177.20 | None | 6.90 | -33.97 | None |
| OPKO Health, Inc. | OPK | 2356.83 | 891.00 | 1.68 | -8.06 | -32.92 |
| Karuna Therapeutics, Inc. | KRTX | 2343.38 | None | 6.12 | -57.78 | None |
| ADC Therapeutics SA | ADCT | 2338.74 | 2.00 | 27.59 | -20.05 | None |
| Turning Point Therapeutics, Inc. | TPTX | 2157.84 | None | 6.49 | -18.05 | None |
| Apellis Pharmaceuticals, Inc. | APLS | 2141.70 | None | 9.46 | -5.13 | None |
| Ra Pharmaceuticals, Inc. | RARX | 2111.78 | 3.00 | 8.68 | -20.78 | -585.71 |
| IGM Biosciences, Inc. | IGMS | 2038.87 | None | 8.98 | -37.58 | None |
| Principia Biopharma, Inc. | PRNB | 1752.24 | 30.00 | 6.24 | -24.93 | -242.01 |
| Springworks Therapeutics, Inc. | SWTX | 1554.02 | None | 5.05 | -24.92 | None |
| Y-mAbs Therapeutics, Inc. | YMAB | 1436.71 | None | 8.80 | -15.59 | None |
| Zymeworks, Inc. | ZYME | 1393.98 | 26.00 | 2.89 | -8.22 | -629.37 |
| Tricida, Inc. | TCDA | 1263.22 | None | 6.49 | -5.98 | None |
| Akcea Therapeutics, Inc. | AKCA | 1232.87 | 341.00 | 2.53 | -43.83 | -8.59 |
| Kiniksa Pharmaceuticals Ltd. | KNSA | 1169.85 | None | 6.06 | -9.67 | None |
| Akero Therapeutics, Inc. | AKRO | 1092.43 | None | 9.12 | -21.53 | None |
| Odonate Therapeutics, Inc. | ODT | 1084.89 | None | 8.89 | -9.64 | None |
| Phibro Animal Health Corp. | PAHC | 1039.35 | 818.00 | 5.25 | 28.17 | 4.49 |
| Arcutis Biotherapeutics, Inc. | ARQT | 1020.09 | None | 4.35 | -16.31 | None |
| Athenex, Inc. | ATNX | 971.88 | 123.00 | 5.96 | -9.03 | -87.86 |
| Constellation Pharmaceuticals, Inc. | CNST | 906.88 | None | 4.27 | -9.77 | None |
| Gossamer Bio, Inc. | GOSS | 774.70 | None | 3.14 | -3.90 | None |
| G1 Therapeutics, Inc. | GTHX | 763.80 | 1.00 | 3.31 | -5.83 | None |
| Phathom Pharmaceuticals, Inc. | PHAT | 735.75 | None | 4.08 | -2.70 | None |
| Quanterix Corp. | QTRX | 726.84 | 60.00 | 6.41 | -16.62 | -71.52 |
| Krystal Biotech, Inc. | KRYS | 695.98 | None | 4.06 | -33.56 | None |
| Oric Pharmaceuticals, Inc. | ORIC | 680.40 | None | -7.39 | -22.50 | None |
| Amneal Pharmaceuticals, Inc. | AMRX | 672.67 | 1679.00 | 4.63 | -3.09 | -11.85 |
| Provention Bio, Inc. | PRVB | 669.94 | None | 10.60 | -15.13 | None |
| Arcturus Therapeutics Holdings, Inc. | ARCT | 655.98 | 19.00 | 60.80 | -23.58 | -151.34 |
| Provention Bio, Inc. | PRVB | 651.88 | None | 10.31 | -14.72 | None |
| Applied Therapeutics, Inc. | APLT | 617.54 | 14.00 | 3.99 | -12.53 | -19.41 |
| Keros Therapeutics, Inc. | KROS | 596.88 | 8.00 | -26.96 | -28.10 | -285.35 |
| Aprea Therapeutics, Inc. | APRE | 569.31 | None | 5.04 | -16.84 | None |
| Oyster Point Pharma, Inc. | OYST | 513.24 | None | 5.16 | -8.92 | None |
| Mirum Pharmaceuticals, Inc. | MIRM | 465.50 | None | 3.03 | -6.87 | None |
| SIGA Technologies, Inc. | SIGA | 460.84 | 19.00 | 5.16 | -23.42 | -94.00 |
| 89bio, Inc. | ETNB | 444.50 | None | 5.48 | -6.89 | None |
| Biospecifics Technologies Corp. | BSTC | 441.21 | 40.00 | 3.58 | 18.87 | 61.80 |
| Fulcrum Therapeutics, Inc. | FULC | 423.89 | 1.00 | 7.14 | -6.14 | None |
| Satsuma Pharmaceuticals, Inc. | STSA | 417.01 | None | 4.10 | -11.46 | None |
| Osmotica Pharmaceuticals Plc | OSMT | 416.88 | 232.00 | 3.16 | -1.52 | -115.44 |
| DURECT Corp. | DRRX | 390.60 | 28.00 | 30.00 | -16.15 | -82.94 |
| Imara, Inc. | IMRA | 375.70 | None | 3.63 | -10.68 | None |
| TCR2 Therapeutics, Inc. | TCRR | 368.88 | None | 2.52 | -36.60 | None |
| Kala Pharmaceuticals, Inc. | KALA | 365.76 | 6.00 | 4.00 | -3.98 | None |
| Relmada Therapeutics, Inc. | RLMD | 363.42 | 0.00 | 5.42 | -30.36 | -877.66 |
| Ocular Therapeutix, Inc. | OCUL | 353.04 | 6.00 | -43.26 | -3.85 | None |
| Crinetics Pharmaceuticals, Inc. | CRNX | 350.16 | 1.00 | 4.42 | -6.00 | -447.78 |
| Ovid Therapeutics, Inc. | OVID | 315.00 | None | 7.45 | -4.83 | None |
| IDEAYA Biosciences, Inc. | IDYA | 283.40 | None | 4.31 | -6.50 | None |
| Aeglea Biotherapeutics, Inc. | AGLE | 276.54 | 4.00 | 8.73 | -3.45 | -523.27 |
| Urovant Sciences Ltd. | UROV | 276.00 | None | -4.89 | -1.91 | None |
| HOOKIPA Pharma, Inc. | HOOK | 250.12 | 13.00 | 2.26 | -5.53 | -333.02 |
| AMAG Pharmaceuticals, Inc. | AMAG | 246.84 | 321.00 | 0.94 | -0.67 | -115.05 |
| Spero Therapeutics, Inc. | SPRO | 242.63 | 12.00 | 3.19 | -2.98 | -656.72 |
| Verrica Pharmaceuticals, Inc. | VRCA | 220.00 | None | 4.02 | -7.21 | None |
| Lannett Co., Inc. | LCI | 218.12 | 542.00 | 0.75 | -7.17 | -5.77 |
| Sutro Biopharma, Inc. | STRO | 207.46 | 41.00 | 3.94 | -3.40 | -148.06 |
| KalVista Pharmaceuticals, Inc. | KALV | 207.00 | 13.00 | 2.45 | -7.01 | -229.44 |
| Veru, Inc. | VERU | 189.15 | 39.00 | 6.47 | -19.40 | -25.53 |
| Kaleido Biosciences, Inc. | KLDO | 184.50 | None | 6.54 | -2.52 | None |
| Galera Therapeutics, Inc. | GRTX | 183.75 | None | 3.43 | -2.79 | None |
| LogicBio Therapeutics, Inc. | LOGC | 177.79 | 1.00 | 5.37 | -4.18 | None |
| Protara Therapeutics, Inc. | TARA | 153.54 | None | 2.31 | -9.96 | None |
| Liquidia Technologies, Inc. | LQDA | 152.57 | 8.00 | 11.96 | -3.10 | -602.17 |
| Avenue Therapeutics, Inc. | ATXI | 149.92 | 532.00 | 27.56 | -10.30 | 26.69 |
| Gritstone Oncology, Inc. | GRTS | 144.72 | 4.00 | 1.30 | -1.39 | None |
| scPharmaceuticals, Inc. | SCPH | 139.08 | 119.00 | 3.55 | -4.44 | -27.05 |
| Lyra Therapeutics, Inc. | LYRA | 138.12 | 1.00 | -1.17 | -8.28 | -491.16 |
| PhaseBio Pharmaceuticals, Inc. | PHAS | 137.17 | 2.00 | 2.54 | -2.87 | None |
| Tyme Technologies, Inc. | TYME | 136.85 | None | 7.93 | -6.26 | None |
| Evelo Biosciences, Inc. | EVLO | 132.80 | None | 4.88 | -1.51 | None |
| Ayala Pharmaceuticals, Inc. | AYLA | 132.48 | 3.00 | -3.12 | -6.42 | -679.19 |
| Harrow Health, Inc. | HROW | 127.66 | 51.00 | 8.18 | -5.17 | -47.54 |
| TFF Pharmaceuticals, Inc. | TFFP | 127.11 | None | 4.92 | -3.28 | None |
| Cyclerion Therapeutics, Inc. | CYCN | 125.28 | 6.00 | 1.58 | -1.21 | None |
| Mustang Bio, Inc. | MBIO | 120.40 | None | 2.81 | -2.45 | None |
| Aquestive Therapeutics, Inc. | AQST | 120.12 | 49.00 | -6.92 | -1.71 | -139.64 |
| Corvus Pharmaceuticals, Inc. | CRVS | 118.90 | None | 1.91 | -2.52 | None |
| Immunic, Inc. | IMUX | 118.50 | None | 3.49 | -53.86 | None |
| NeuBase Therapeutics, Inc. | NBSE | 116.06 | None | 48.76 | -2.60 | None |
| Evolus, Inc. | EOLS | 91.80 | 45.00 | 1.65 | -0.91 | -217.51 |
| Eton Pharmaceuticals, Inc. | ETON | 89.28 | 1.00 | 9.73 | -4.47 | None |
| Trevi Therapeutics, Inc. | TRVI | 88.56 | None | 1.88 | -3.02 | None |
| Milestone Pharmaceuticals, Inc. | MIST | 88.00 | None | 0.87 | -1.41 | None |
| EyePoint Pharmaceuticals, Inc. | EYPT | 77.97 | 26.00 | 5.50 | -1.59 | -196.30 |
| Xeris Pharmaceuticals, Inc. | XERS | 76.72 | 4.00 | 3.81 | -0.59 | None |
| Clearside Biomedical, Inc. | CLSD | 71.34 | 6.00 | 9.16 | -4.05 | -293.61 |
| Aridis Pharmaceuticals, Inc. | ARDS | 67.05 | 1.00 | -27.59 | -2.29 | -851.00 |
| Navidea Biopharmaceuticals, Inc. | NAVB | 64.77 | 1.00 | -47.62 | -5.86 | -65.13 |
| Checkpoint Therapeutics, Inc. | CKPT | 64.60 | 2.00 | 5.57 | -2.78 | -949.53 |
| Baudax Bio, Inc. | BXRX | 63.54 | None | -1.73 | -0.91 | None |
| BiomX, Inc. | PHGE | 60.50 | None | 1.59 | -1.41 | None |
| Assertio Therapeutics, Inc. | ASRT | 58.64 | 192.00 | 1.02 | -0.36 | -83.99 |
| Genprex, Inc. | GNPX | 55.10 | None | 4.68 | -4.03 | None |
| Aerpio Pharmaceuticals, Inc. | ARPO | 49.20 | 20.00 | 1.48 | -2.61 | -51.58 |
| Menlo Therapeutics, Inc. | MNLO | 46.98 | 2.00 | 3.95 | -0.50 | -483.51 |
| Eyenovia, Inc. | EYEN | 42.56 | None | 4.29 | -2.08 | None |
| Annovis Bio, Inc. | ANVS | 42.28 | None | 3.87 | -33.56 | None |
| Edesa Biotech, Inc. | EDSA | 41.85 | 0.00 | 5.96 | -0.44 | -395.23 |
| Moleculin Biotech, Inc. | MBRX | 39.38 | None | 3.42 | -4.28 | None |
| Akari Therapeutics Plc | AKTX | 36.18 | None | -33.50 | -2.01 | None |
| Adamis Pharmaceuticals Corp. | ADMP | 35.44 | 22.00 | 1.36 | -1.20 | -140.33 |
| Acer Therapeutics, Inc. | ACER | 35.00 | 3.00 | 2.55 | -1.34 | -274.69 |
| AgeX Therapeutics, Inc. | AGE | 34.83 | 2.00 | -45.84 | -2.86 | -658.11 |
| Mannatech, Inc. | MTEX | 34.80 | 156.00 | 1.47 | 7.84 | 3.45 |
| Citius Pharmaceuticals, Inc. | CTXR | 33.21 | None | 2.46 | -1.92 | None |
| Allena Pharmaceuticals, Inc. | ALNA | 31.28 | None | 4.12 | -0.72 | None |
| Oncternal Therapeutics, Inc. | ONCT | 31.07 | 3.00 | 3.98 | -1.23 | -225.89 |
| CNS Pharmaceuticals, Inc. | CNSP | 27.04 | None | 4.69 | -4.97 | None |
| Hoth Therapeutics, Inc. | HOTH | 25.10 | None | 6.97 | -2.79 | None |
| Aileron Therapeutics, Inc. | ALRN | 24.60 | None | 3.51 | -0.92 | None |
| Millendo Therapeutics, Inc. | MLND | 24.15 | 0.00 | 0.57 | -0.52 | None |
| Akorn, Inc. | AKRX | 22.68 | 721.00 | -1.20 | -0.06 | -55.64 |
| Spring Bank Pharmaceuticals, Inc. | SBPH | 22.40 | 0.00 | 0.85 | -0.86 | None |
| ProPhase Labs, Inc. | PRPH | 19.08 | 9.00 | 1.73 | -6.36 | -31.15 |
| Daré Bioscience, Inc. | DARE | 18.91 | 1.00 | 8.29 | -1.13 | None |
| Adial Pharmaceuticals, Inc. | ADIL | 14.80 | None | 3.61 | -1.95 | None |
| Novan, Inc. | NOVN | 14.48 | 5.00 | -3.33 | -0.46 | -602.34 |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| PDS Biotechnology Corp. | PDSB | 13.09 | None | 1.45 | -0.51 | None |
| Titan Pharmaceuticals, Inc. | TTNP | 11.60 | 4.00 | 4.83 | -0.64 | -437.91 |
| Novus Therapeutics, Inc. | NVUS | 7.74 | None | 0.66 | -0.37 | None |
| Brickell Biotech, Inc. | BBI | 4.50 | 5.00 | 1.48 | -0.06 | -432.19 |
| BioStar Pharmaceuticals, Inc. | BSPM | 0.21 | 0.00 | 0.01 | 0.10 | 294.01 |
Latest insider transactions
| Date | Role | Name | Transaction | Quantity | Quantity Owned After |
|---|
AgeX Therapeutics Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
AgeX Therapeutics, Inc. Appoints Andrea Park as Chief Financial Officer
AgeX Therapeutics , Inc. ("AgeX": NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that Andrea Park has been appointed Chief ...
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A
universal immune-protected therapeutic cells for Sernova’s Cell Pouch TM Platform AgeX Therapeutics, Inc. ("AgeX": NYSE American: AGE), a biotechnology company developing therapeutics for human ...
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
AgeX Therapeutics, Inc. ("AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on June 1, 2020 AgeX received a ...
BRIEF-Agex Therapeutics And Pluristyx Announce Manufacturing, Marketing, And Distribution Deal
June 16 (Reuters) - AgeX Therapeutics Inc: * AGEX THERAPEUTICS AND PLURISTYX ANNOUNCE MANUFACTURING, MARKETING, AND DISTRIBUTION AGREEMENT TO EXPAND ACCESS TO CLINICAL-GRADE HUMAN PLURIPOTENT STEM ...
AgeX Therapeutics Issues Year-End Letter to Shareholders
Before it's here, it's on the Bloomberg Terminal.
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A
ALAMEDA, Calif. & LONDON, Ontario--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for ...